Treatment of psoriasis with etanercept in immunocompromised patients: Two case reports

Clara De Simone, Ketty Peris, Francesca Perino, Giacomo Caldarola, Magda D'Agostino

Risultato della ricerca: Contributo in rivistaArticolo in rivista

9 Citazioni (Scopus)

Abstract

Tumour necrosis factor (TNF)-α blocking agents have revolutionized the treatment of psoriasis and psoriatic arthritis. Concerns remain about increased susceptibility to infection and onset of malignancies, and the use of TNF-α agents in patients with HIV infection or undergoing immunosuppressant treatment is debated. We report cases of severe plaque psoriasis in a patient with HIV infection and in a liver transplant recipient who were successfully treated with etanercept, an anti-TNF-α agent, without notable side-effects.
Lingua originaleEnglish
pagine (da-a)67-71
Numero di pagine5
RivistaJournal of International Medical Research
Volume44
DOI
Stato di pubblicazionePubblicato - 2016

Keywords

  • Antitumour necrosis factor-α agents
  • Biochemistry
  • Biochemistry (medical)
  • Cell Biology
  • Medicine (all)
  • comorbidities
  • etanercept
  • psoriasis
  • psoriatic arthritis

Fingerprint

Entra nei temi di ricerca di 'Treatment of psoriasis with etanercept in immunocompromised patients: Two case reports'. Insieme formano una fingerprint unica.

Cita questo